Full-Time

Director – Global Regulatory Strategy

Oncology

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA + 2 more

More locations: Princeton, NJ, USA | Bethesda, MD, USA

70/30 work model requiring 70% in-office presence.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • BA/BS degree in a scientific/engineering discipline required. PharmD, Masters or PhD preferred.
  • 10+ years of experience in the Pharmaceutical industry
  • 8+ years of experience in Regulatory strategy, including specifically: Oncology Development
  • Expert knowledge of relevant FDA, EU, ICH guidelines and regulations related to Oncology programs.
  • Strong experience with CTD format and content regulatory filings
  • Experience with developing and implementing competitive regulatory strategies
  • Demonstrated track record in securing product approvals and maintaining a complex portfolio is preferred
  • Knowledge of and broad experience with regulatory procedures and legislation for drug development, product registration, line extension and license maintenance – preferably from at least both US and EU
  • Direct experience of leading regulatory authority meetings in different phases of drug development
  • Regulatory knowledge across therapeutic areas including Oncology development is preferable.
  • Preferred: Delivery of at least one major application (NDA/BLA/MAA/JNDA etc.)
  • Ability to work independently to manage multiple projects in a fast-paced environment.
  • Ability to collaborate effectively in a dynamic, cross-functional matrix environment to drive meeting each program’s critical regulatory milestones.
  • Partners with internal teams and Moderna partners to develop content and manage submissions to regulatory bodies.
  • Effectively communicate the regulatory strategy, risks, mitigations and overall plans to Regulatory Affairs, the Project Team and senior management, as relevant.
  • Identify areas in need of improvement and lead the development and implementation of process improvements.
  • Outstanding communication skills (verbal and written) and willingness to share knowledge and lessons learned.
Responsibilities
  • Serve as global regulatory lead accountable for all regulatory aspects of his or her assigned project(s), including development and implementation of the global regulatory development plan for the project
  • Represent Regulatory Affairs on cross-functional project teams.
  • Ensure the global regulatory strategy for assigned project(s) is consistent with the business objectives and have been negotiated with relevant health authorities as appropriate.
  • Effectively communicate the regulatory strategy, risks, mitigations and overall plans to the Regulatory Affairs Management Team, Project Development Team and senior management, as relevant.
  • Collaborates with internal teams and Moderna partners to achieve project goals, including development content and management of submissions to Health Agencies.
  • Sets strategic direction and leads the development of content, format and accountability for regulatory submissions and related supplements and amendments.
  • Advises project teams regarding the development and implementation of regulatory strategy through the clinical and nonclinical development processes.
  • Monitors regulatory developments related to mRNA platform and advises project teams regarding the development and implementation of regulatory strategy through the clinical development processes.
  • Establishes and maintains excellent relationships with regulatory agency personnel.
  • Negotiates directly and effectively with health agencies regarding company's filings. Responds to requests for additional data, organizes and manages participation in meetings.
  • Reviews and approves technical data and verifies accuracy of clinical data and execution of clinical projects to regulatory authorities.
  • Develops, implements, and reviews current policies and practices in compliance with Federal and international regulatory agencies.
  • Monitors regulatory publications to keep apprised of new or changing regulatory developments and potential strategic impact.
  • Serves as regulatory science representative to provide input on trials and filing activities and to ensure that report systems are maintained and compliant.
  • Supports development and maintenance of the Target Label Profile and the Company Core Data Sheet.
  • Identifies areas in need of improvement and lead the development and implementation of process improvements.
  • Conducts risks and gaps assessment and identifies potential areas of regulatory concern and responds to new government/regulatory developments.
  • Manages resources for assigned project(s), including ensuring adequate regulatory resources, skills, and budgets are available to deliver the project deliverables.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?